| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 05/05/1998 | US5746995 Diethylenetriaminepentaacetic acid |
| 05/05/1998 | US5746208 Method of magnetic resonance arteriography using contrast agents |
| 05/05/1998 | CA2088588C Treatment of hair loss and dermatological problems |
| 04/30/1998 | WO1998017782A1 Method for producing transgenic animal models with modulated phenotype and animals produced therefrom |
| 04/30/1998 | WO1998017324A2 Improvements in or relating to contrast agents |
| 04/30/1998 | WO1998017318A1 Use of hollow microcapsules in diagnosis and therapy |
| 04/30/1998 | WO1998017257A1 Porous microcapsules and their use as therapeutic and diagnostic vehicles |
| 04/30/1998 | DE19644501A1 GABA¶A¶-Rezeptoruntereinheit epsilon-verwandtes Protein GABA¶A¶ receptor epsilon subunit-related protein |
| 04/30/1998 | CA2269252A1 Porous microcapsules and their use as therapeutic and diagnostic vehicles |
| 04/29/1998 | EP0837934A1 Human vascular endothelial growth factor 2 |
| 04/29/1998 | EP0837696A1 Improved delivery of diagnostic and therapeutic agents to a target site |
| 04/29/1998 | EP0837641A1 Coatings for production of hyperpolarized noble gases |
| 04/29/1998 | EP0662005B1 Microparticle preparations made from biodegradable copolymers |
| 04/29/1998 | CN1180316A Diagnostic marker |
| 04/29/1998 | CN1180310A Novel compositions of lipids and stabilizing materials |
| 04/29/1998 | CN1180304A Method of magnetic resonance focused surgical and therapeutic ultrasound |
| 04/28/1998 | US5744153 Liquid delivery compositions |
| 04/28/1998 | CA1339840C Method and apparatus for screening cells or formed bodies with populations expressing selected characteristics |
| 04/23/1998 | WO1998016627A1 Transgenic non-human mammal expressing flag-app-c100 fusion protein |
| 04/23/1998 | WO1998016257A2 Stabilized microparticles and their use as ultrasound contrast agents |
| 04/23/1998 | WO1998016256A1 Magnetic resonance imaging of thrombi |
| 04/23/1998 | CA2268763A1 Stabilized microparticles and their use as ultrasound contrast agents |
| 04/22/1998 | EP0836485A2 Cascade polymer complexes |
| 04/22/1998 | EP0836420A1 Methods and apparatus for performing diagnostic and therapeutic ultrasound simultaneously |
| 04/22/1998 | EP0836418A1 Microfabricated devices for diagnostic applications |
| 04/22/1998 | EP0725633A4 Detection of h. pylori in the stomach |
| 04/21/1998 | US5741893 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| 04/21/1998 | US5741670 Polypeptides |
| 04/21/1998 | US5741522 Contrast agents for use with ultrasound |
| 04/21/1998 | US5741478 Preparation of hollow microcapsules by spray-drying an aqueous solution of a wall-forming material and a water-miscible solvent |
| 04/21/1998 | US5741477 Negative contrast agents for magnetic resonance imaging comprising barium sulfate and a clay |
| 04/21/1998 | US5740807 Suspended ultra-sound induced microbubble cavitation imaging |
| 04/16/1998 | WO1998015569A1 Gp120 polypeptides having conformational discontinuous chemokine receptor binding sites and methods of inhibiting hiv infection |
| 04/16/1998 | WO1998015277A2 Cns-penetrant nk-1 receptor antagonists as antidepressant and/or an anti-anxiety agents |
| 04/16/1998 | WO1998009600A3 Novel silicon amphiphilic compounds and the use thereof |
| 04/16/1998 | CA2267662A1 Gp120 polypeptides having conformational discontinuous chemokine receptor binding sites and methods of inhibiting hiv infection |
| 04/16/1998 | CA2266773A1 Use of a nk-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent |
| 04/15/1998 | EP0835664A2 Improvements in or relating to contrast agents |
| 04/15/1998 | EP0835327A1 Methods for testing of therapeutic compounds |
| 04/15/1998 | EP0835259A1 Iodine-containing peptides and their use as x-ray contrast media |
| 04/15/1998 | EP0835140A2 Metal complexes of polyaminoacids, and their utilization in diagnostic imaging |
| 04/15/1998 | EP0835139A2 Solid oral diagnostic test meal and methods of use thereof |
| 04/15/1998 | EP0835138A1 Preparation for diagnostic of the metabolic syndrome and diseases including the syndrome |
| 04/15/1998 | CN1179108A Contrast media for in vivo imaging based on light transmission on reflection |
| 04/15/1998 | CN1179106A Recombinant human alpha-fetoprotein and uses thereof |
| 04/15/1998 | CN1178704A Demethyl coclanrine water injection for coronary heart disease diagnosis |
| 04/14/1998 | US5739313 Radionuclide labeling of vitamin B12 and coenzymes thereof |
| 04/14/1998 | US5739294 Bicyclopol yazamacrocyclophosphonic acid complexes for use as contrast agents |
| 04/14/1998 | US5739032 Isolated nucleic acid encodes a glycoprotein for treating leukocyte adhesion deficiency |
| 04/14/1998 | US5738838 Metal ion-binding domains are labeled with medically useful metal ions for lung imaging |
| 04/14/1998 | US5738837 Lanthanide paramagnetic agents for magnetometric imaging |
| 04/14/1998 | US5738113 Caries treatment method with fluoride |
| 04/14/1998 | CA1339821C Magnetic resonance imaging agents |
| 04/09/1998 | WO1998014186A1 Substances and their uses |
| 04/09/1998 | WO1998014175A1 Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof |
| 04/09/1998 | WO1998014174A1 Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| 04/09/1998 | WO1998001163A3 Pseudopolyrotaxanes |
| 04/08/1998 | EP0833670A2 Rotavirus enterotoxin nsp4 and methods of using same |
| 04/08/1998 | EP0833669A2 Gas emulsions stabilized with fluorinated ethers having low ostwald coefficients |
| 04/08/1998 | EP0439508B1 Polyethylene glycolcol (peg)-protein adducts and process for their fractionation |
| 04/08/1998 | CN1178522A Radiographic contrasting agent for computerised tomography and urography |
| 04/08/1998 | CN1178521A Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 04/07/1998 | US5736411 Chiral shift reagent for NMR comprising saccharide derivative |
| 04/07/1998 | US5736340 Secreted Mac-2-binding glycoprotein |
| 04/07/1998 | US5736121 Administering stabilized aqueous suspension of gaseous precursor to patient, allowing phase transition form liquid to gas, scanning |
| 04/07/1998 | US5736119 Using a naturally-occuring protein that chelated metal ions and has a molecular weight of at least 60,000 daltons |
| 04/07/1998 | US5735279 SQUID magnetometry using ferro-, ferri- are paramagnetic particles |
| 04/02/1998 | WO1998013476A1 Transgenic model for heart failure |
| 04/02/1998 | WO1998013338A1 Ion pairs, process for producing the same and their use as contrast agents |
| 04/02/1998 | WO1998013071A1 Gene therapy for inhibition of angiogenesis |
| 04/02/1998 | WO1998013058A1 Methods for treating an ischemic disorder and improving stroke outcome |
| 04/02/1998 | CA2266419A1 Gene therapy for inhibition of angiogenesis |
| 04/01/1998 | EP0832150A1 Cascade polymers with iodine-containing aromatic compounds |
| 04/01/1998 | EP0832068A1 Stable reagents for the preparation of radiopharmaceuticals |
| 04/01/1998 | EP0832054A1 Heterocyclic methyl free radicals as image enhancing agents |
| 04/01/1998 | EP0831939A1 Structurally determined metallo-constructs and applications |
| 04/01/1998 | EP0831935A1 Gaseous ultrasound contrast agents and method therefor |
| 04/01/1998 | EP0831934A2 Preparation and use of contrast agents |
| 04/01/1998 | EP0831933A1 Site specific binding system, imaging compositions and methods |
| 04/01/1998 | EP0831932A1 Novel targeted compositions for diagnostic and therapeutic use |
| 04/01/1998 | EP0831931A1 An in vivo and in vitro model of cutaneous photoaging |
| 04/01/1998 | EP0831930A1 Chelating polymers as contrast agents for medical imaging |
| 04/01/1998 | EP0831929A2 Gas-filled amino acid block co-polymer microspheres |
| 04/01/1998 | EP0831928A2 Magnetic resonance imaging agents for the detection of physiological agents |
| 04/01/1998 | EP0831927A1 Stabilized compositions of fluorinated amphiphiles as contrast agents for ultrasound |
| 04/01/1998 | EP0831926A1 Improvements in or relating to contrast agents |
| 04/01/1998 | EP0831909A1 Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins |
| 04/01/1998 | EP0831904A1 Treatment and diagnosis of prostate cancer |
| 04/01/1998 | EP0831840A1 Use of non-steroidal anti-inflammatory agents to improve the physiological compatibility of particular pharmaceutical preparations |
| 04/01/1998 | EP0788348A4 Container with multi-phase composition for use in diagnostic and therapeutic applications |
| 03/31/1998 | US5734011 Ligand precursors for incorporation into peptides |
| 03/31/1998 | US5733903 Treatment of neoplastic tissue by water-soluble texaphyrine metal complexes |
| 03/31/1998 | US5733572 Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles |
| 03/31/1998 | US5733528 Paramagnetic chelates for nuclear magnetic resonance diagnosis |
| 03/31/1998 | US5733527 Microbubbles |
| 03/31/1998 | US5733525 Method of EII using a water insoluble particulate agent |
| 03/31/1998 | US5733522 Useful for nmr diagnosis and diagnostic radiology; for contrasting the hepatobiliary system |
| 03/31/1998 | US5732707 Blood flow |
| 03/31/1998 | US5732705 Ultrasound diagnostic apparatus |
| 03/31/1998 | CA2103462C X-ray contrast agent |